Keymed Biosciences, Inc.'s total assets for Q2 2024 were ¥3.81B, a decrease of -2.00% from the previous quarter. HK:2162 total liabilities were ¥1.17B for the fiscal quarter, a 30.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.